Review article: targeting the B cell activation system in autoimmune hepatitis.
Albert J CzajaPublished in: Alimentary pharmacology & therapeutics (2021)
The B cell activation system has profound effects on B and T cell function in autoimmune diseases. Blockade therapy is being actively evaluated in autoimmune hepatitis. Clarification of the critical pathogenic components of the B cell activation system will improve the targeting, efficacy, and safety of blockade therapy in this disease.